Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
BLA Accepted in China for Boan Biotech's Denosumab Injection (BA1102) for the Oncology Indications 2023-03-21 13:46
Innovent Announces Clinical Data of Multiple Trials Will be Presented at the AACR Annual Meeting 2023 2023-03-21 08:00
Saudi's Space Mission will be for the Benefit of Science 2023-03-21 00:31
Sirnaomics to Present Latest Developments in Polypeptide Nanoparticle Platform at the 4th Annual RNAi-Based Therapeutics Summit 2023-03-20 23:27
Transcenta Holding Limited (6628.HK) to Hold 2022 Annual Results Release Conference Call 2023-03-20 21:12
Hovione and Ripple Enter Strategic Partnership to Expand Epidel® Platform into Non-Ophthalmic Space 2023-03-20 21:00
Guo Guangchang Stresses Healthy Corporate Development and Expresses Full Confidence in the Future 2023-03-20 17:12
ETANA HAS SECURED FINANCING FROM DEG, EAST VENTURES AND OTHER GLOBAL INVESTORS 2023-03-20 15:22
Antengene Announces Five Upcoming Presentations at the 2023 American Association for Cancer Research Annual Meeting 2023-03-20 15:20
Izokibep Phase 2b/3 Hidradenitis Suppurative Data Presented at the 2023 American Academy of Dermatology Annual Meeting 2023-03-20 08:41
AMGEN AND NSG BIOLABS ANNOUNCE ALBATROZ THERAPEUTICS AS WINNER OF FIRST AMGEN GOLDEN TICKET IN SINGAPORE 2023-03-20 08:00
Keymed Biosciences Announces 2022 Annual Results: Efficiently Promotes Clinical Progress & Proactively Develops Global Strategic Collaboration 2023-03-18 08:00
Hanmi Pharmaceutical's Combination Drug for Dyslipidemia Treatment, 'Rosuzet': Confirmed Non-inferiority Efficacy and Safety Compared to Monotherapy in 'The Lancet' & 'European Heart Journal' 2023-03-17 21:00
Samsung Biologics announces construction of Plant 5 to commence Bio Campus II capacity expansion 2023-03-17 19:25
SYMBYX announces promising Sydney Adventist Hospital clinical trial results for Parkinson's using the SYMBYX Neuro - a new light therapy wellness helmet 2023-03-17 18:30
GCCL Develops PBMC Resource Management System 2023-03-17 09:26
YS BIOPHARMA TO RING THE OPENING BELL AND DEBUT ON NASDAQ 2023-03-17 04:30
Nav1.7 Selective Inhibitor OLP-1002 Shows Strong Efficacy and Long Therapeutic Duration according to Interim Findings from a Phase 2a Study in OA Patients 2023-03-16 21:00
Angel Yeast Showcases Latest Product Innovations at Food Ingredients China 2023 2023-03-16 20:16
Alphamab Oncology Announces the First Patient Dosed in the Phase I Trial of Anti-HER2 bispecific ADC JSKN003 2023-03-16 09:58
1 120 121 122 123 124 453